Literature DB >> 33225408

Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis.

Víctor Lopez-Lopez1, Juan José Ruiz-Manzanera2, Dilmurodjon Eshmuminov3, Kuno Lehmann3, Marcel Schneider3, Markus von der Groeben4, David Ruiz de Angulo2, Ursula Gajownik5, Jose Antonio Pons5, Francisco Sánchez-Bueno2, Ricardo Robles-Campos2, Pablo Ramírez-Romero2.   

Abstract

BACKGROUND: Obesity-related non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are two main causes of end-stage liver disease requiring a liver transplantation. Studies exploring bariatric surgery in the liver transplantation setting have increased in recent years; however, a systematic analysis of the topic is lacking to date. This meta-analysis was conducted to explore the perioperative and long-term outcomes of bariatric surgery in obese patients undergoing liver transplantation.
METHODS: Electronic databases were systematically searched for studies reporting bariatric surgery in patients undergoing liver transplantation. The primary outcomes were postoperative complications and mortality. We also extracted data about excess weight loss, body mass index, and improvement of comorbidities after bariatric surgery.
RESULTS: A total of 96 patients from 8 articles were included. Bariatric surgery-related morbidity and mortality rates were 37% (95% CI 0.27-0.47) and 0.6% (95% CI 0.02-0.13), respectively. Body mass index at 24 months was 31.02 (95% CI 25.96-36.09) with a percentage excess weight loss at 12 and 24 months of 44.08 (95% CI 27.90-60.26) and 49.2 (95% CI 31.89-66.66), respectively. After bariatric surgery, rates of improvement of arterial hypertension and diabetes mellitus were 61% (95% CI 0.45-0.75) and 45% (95% CI 0.25-0.66), respectively. In most patients, bariatric surgery was performed after liver transplant and the most frequent technique was sleeve gastrectomy.
CONCLUSIONS: Bariatric surgery can be performed safely in the setting of liver transplantation resulting in improvement of obesity-related comorbidities. The optimal timing and technique require further studies.

Entities:  

Keywords:  Bariatric surgery; Liver transplant; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Obesity

Mesh:

Year:  2020        PMID: 33225408     DOI: 10.1007/s11695-020-05118-7

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  50 in total

Review 1.  Metabolic syndrome and liver transplantation: a review and guide to management.

Authors:  Kymberly D S Watt; Michael R Charlton
Journal:  J Hepatol       Date:  2010-03-31       Impact factor: 25.083

2.  Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation.

Authors:  Paul J Thuluvath
Journal:  Liver Transpl       Date:  2007-12       Impact factor: 5.799

3.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

Review 4.  The impact of obesity on surgical outcomes: a review.

Authors:  P S Choban; L Flancbaum
Journal:  J Am Coll Surg       Date:  1997-12       Impact factor: 6.113

5.  OPTN/SRTR 2017 Annual Data Report: Liver.

Authors:  W R Kim; J R Lake; J M Smith; D P Schladt; M A Skeans; S M Noreen; A M Robinson; E Miller; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2019-02       Impact factor: 8.086

6.  Weight and Metabolic Outcomes 12 Years after Gastric Bypass.

Authors:  Ted D Adams; Lance E Davidson; Sheldon E Litwin; Jaewhan Kim; Ronette L Kolotkin; M Nazeem Nanjee; Jonathan M Gutierrez; Sara J Frogley; Anna R Ibele; Eliot A Brinton; Paul N Hopkins; Rodrick McKinlay; Steven C Simper; Steven C Hunt
Journal:  N Engl J Med       Date:  2017-09-21       Impact factor: 91.245

7.  Obesity increases mortality in liver transplantation--the Danish experience.

Authors:  Jens G Hillingsø; André Wettergren; Masanobu Hyoudo; Preben Kirkegaard
Journal:  Transpl Int       Date:  2005-11       Impact factor: 3.782

8.  The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database.

Authors:  J Leonard; J K Heimbach; M Malinchoc; K Watt; M Charlton
Journal:  Am J Transplant       Date:  2008-03       Impact factor: 8.086

9.  Prolonged waiting times for liver transplantation in obese patients.

Authors:  Dorry L Segev; Richard E Thompson; Jayme E Locke; Christopher E Simpkins; Paul J Thuluvath; Robert A Montgomery; Warren R Maley
Journal:  Ann Surg       Date:  2008-11       Impact factor: 12.969

10.  Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.

Authors:  Debashis Haldar; Barbara Kern; James Hodson; Matthew James Armstrong; Rene Adam; Gabriela Berlakovich; Josef Fritz; Benedikt Feurstein; Wolfgang Popp; Vincent Karam; Paolo Muiesan; John O'Grady; Neville Jamieson; Stephen J Wigmore; Jacques Pirenne; Seyed Ali Malek-Hosseini; Ernest Hidalgo; Yaman Tokat; Andreas Paul; Johann Pratschke; Michael Bartels; Pavel Trunecka; Utz Settmacher; Massimo Pinzani; Christophe Duvoux; Philip Noel Newsome; Stefan Schneeberger
Journal:  J Hepatol       Date:  2019-05-07       Impact factor: 25.083

View more
  2 in total

1.  Combined liver transplantation with sleeve gastrectomy: a pioneer case series from Brazil.

Authors:  Eduardo de Souza M Fernandes; Felipe Pedreira Tavares de Mello; Leandro Savattone Pimentel; Ronaldo de Oliveira Andrade; Camila Girão; Camilla César; Luciana Janene El-Kadre; Fernando de Barros; Henrique Sergio Moraes Coelho; Anderson Brito; Claudia Cristina Tavares de Sousa; Orlando Jorge M Torres
Journal:  Updates Surg       Date:  2022-02-01

Review 2.  Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease.

Authors:  Lukas Hartl; Joshua Elias; Gerhard Prager; Thomas Reiberger; Lukas W Unger
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.